VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing

被引:19
|
作者
Meeson, Richard [1 ,2 ]
Sanghani-Keri, Anita [1 ]
Coathup, Melanie [1 ,3 ]
Blunn, Gordon [1 ,4 ]
机构
[1] Univ Coll London, Div Surg, Stanmore, Middx, England
[2] Royal Vet Coll, Hatfield, Herts, England
[3] Univ Cent Florida, Orlando, FL 32816 USA
[4] Univ Portsmouth, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
mobilization; mesenchymal stem cells; AMD3100; VEGF; fracture healing; BONE-MARROW; PERIPHERAL-BLOOD; PROGENITOR CELLS; IN-VIVO; BIOLOGICAL CHARACTERISTICS; PRECURSOR CELLS; ANGIOGENESIS; MIGRATION; REPAIR; ANTAGONIST;
D O I
10.1002/jor.24164
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A significant number of fractures develop non-union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non-invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex-breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi-differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12-14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 +/- 1.7 mu m(3) and trabecular thickness 0.05 +/- 0.01 mu m compared with control animals (4.3 +/- 3.1 mu m(3), 0.04 +/- 0.01 mu m, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre-clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non-union fractures. (c) 2018 The Authors. Journal of Orthopaedic Research (R) Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294-1302, 2019.
引用
收藏
页码:1294 / 1302
页数:9
相关论文
共 50 条
  • [21] AMD3100 and G-CSF for poor mobilisers; successful harvest of stem cells in a child with cancer
    Bateman, CM
    Stephen, K
    Calandra, G
    Shaw, PJ
    BONE MARROW TRANSPLANTATION, 2005, 35 : S105 - S105
  • [22] AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
    Yu, M.
    Gang, E. J.
    Parameswaran, R.
    Stoddart, S.
    Fei, F.
    Schmidhuber, S.
    Park, E.
    Hsieh, Y. T.
    Yang, A. S.
    Groffen, J.
    Heisterkamp, N.
    Kim, Y. M.
    BLOOD CANCER JOURNAL, 2011, 1 : e14 - e14
  • [23] Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells
    Liesveld, Jane L.
    Bechelli, Jeremy
    Rosell, Karen
    Lu, Chaohui
    Bridger, Gary
    Phillips, Gordon, II
    Abboud, Camille N.
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1553 - 1563
  • [24] AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
    M Yu
    E J Gang
    R Parameswaran
    S Stoddart
    F Fei
    S Schmidhuber
    E Park
    Y T Hsieh
    A S Yang
    J Groffen
    N Heisterkamp
    Y M Kim
    Blood Cancer Journal, 2011, 1 : e14 - e14
  • [25] Significant mobilization of both conventional and regulatory T cells with AMD3100
    Kean, Leslie S.
    Sen, Sharon
    Onabajo, Olusegun
    Singh, Karnail
    Robertson, Jennifer
    Stempora, Linda
    Bonifacino, Aylin C.
    Metzger, Mark E.
    Promislow, Daniel E. L.
    Mattapallil, Joseph J.
    Donahue, Robert E.
    BLOOD, 2011, 118 (25) : 6580 - 6590
  • [26] AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse
    Samuelson, Clare
    Radtke, Stefan
    Cui, Margaret
    Perez, Anai
    Kiem, Hans-Peter
    Humbert, Olivier
    EXPERIMENTAL HEMATOLOGY, 2021, 93 : 52 - U21
  • [27] Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke
    Helene L Walter
    Gerlinde van der Maten
    Ana Rita Antunes
    Tadeusz Wieloch
    Karsten Ruscher
    Journal of Neuroinflammation, 12
  • [28] Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke
    Walter, Helene L.
    van der Maten, Gerlinde
    Antunes, Ana Rita
    Wieloch, Tadeusz
    Ruscher, Karsten
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [29] Mesenchymal stem cells and fracture healing - Commentary
    Hak, David J.
    ORTHOPEDICS, 2008, 31 (09) : 856 - 856
  • [30] The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+cells than G-CSF
    Seeger, T
    Veldwijk, M
    Bridger, G
    Calandra, G
    Goldschmidt, H
    Ho, A
    Fruehauf, S
    BLOOD, 2005, 106 (11) : 558A - 558A